Lunit (KRX: 328130) , a leading provider of AI for cancer diagnostics and precision oncology, today announced that a new study evaluating its AI-powered pathology solution, Lunit SCOPE HER2, has been ...

Every long-term couple will tell you that relationships are basically trust and commitment. Observe them and you’ll notice ...

If 2024 was the year of proof-of-concept and 2025 was the year of early adoption and scale, 2026 is shaping up to be something different — a year defined by normalization. AI in healthcare won't fade ...

Background Early cardiovascular disease risk detection opportunities are limited in men, whereas gestational diabetes, ...

The Worrier’s Guide to Life by Gemma Correll Andrews McMeel Publishing 2015, 112 pages, 6.5 x 8 x 0.4 inches (softcover) ...

In the study, less intensive follow-up was associated with a lower lung cancer risk through 1 and 2 years, "but this still ...

New multifaceted AI integrates MRI and clinical data, crucially analyzes tumor texture and breast symmetry, identifying early ...

FDA expands labels for Roche's PATHWAY HER2 (4B5) test* and VENTANA HER2 Dual ISH DNA Probe Cocktail, which can now be used to identify HER2-positive metastatic breast cancer patients that could be ...

Happy relationships protect heart health as strongly as traditional risk factors, but most cardiac care ignores this ...

With the CDC's Advisory Committee on Immunization Practices (ACIP) recommending post-vaccination antibody testing for ...

Edmonton, AB – December 22, 2025 – PRESSADVANTAGE – A first in western Canada, access to TIER-1 ENDOSURE testing for the ...